Adage Capital Partners Gp, L.L.C. Legend Biotech Corp Transaction History

Adage Capital Partners Gp, L.L.C.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$57.25 - $69.74 $62.6 Million - $76.3 Million	-1,093,510 Reduced 64.0%	615,000 $37 Million
Q3 2023 Nov 14, 2023	BUY	$63.16 - $76.5 $54.3 Million - $65.8 Million	860,410 Added 101.45%	1,708,510 $115 Million
Q2 2023 Aug 14, 2023	BUY	$46.28 - $75.01 $39.3 Million - $63.6 Million	848,100 New	848,100 $58.5 Million
Q3 2022 Nov 14, 2022	SELL	$38.15 - $57.1 $23.7 Million - $35.5 Million	-620,948 Reduced 51.75%	579,052 $23.6 Million
Q2 2022 Aug 15, 2022	BUY	$33.54 - $55.0 $13.1 Million - $21.5 Million	390,000 Added 48.15%	1,200,000 $66 Million
Q1 2022 May 16, 2022	BUY	$31.02 - $48.18 $10.9 Million - $16.9 Million	350,000 Added 76.09%	810,000 $29.4 Million
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $8.64 Million - $12 Million	210,000 Added 84.0%	460,000 $21.4 Million
Q3 2021 Nov 15, 2021	BUY	$35.31 - $50.56 $8.83 Million - $12.6 Million	250,000 New	250,000 $12.6 Million
Q2 2021 Aug 16, 2021	SELL	$25.8 - $41.09 $33.5 Million - $53.4 Million	-1,300,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$23.55 - $32.4 $16.5 Million - $22.7 Million	-700,000 Reduced 35.0%	1,300,000 $37.7 Million
Q4 2020 Feb 16, 2021	BUY	$25.8 - $32.39 $7.04 Million - $8.83 Million	272,733 Added 15.79%	2,000,000 $56.3 Million
Q3 2020 Nov 16, 2020	BUY	$27.5 - $39.61 $19 Million - $27.4 Million	692,095 Added 66.86%	1,727,267 $53.3 Million
Q2 2020 Aug 14, 2020	BUY	$36.1 - $42.56 $37.4 Million - $44.1 Million	1,035,172 New	1,035,172 $44.1 Million

225

74.3M

279K

350K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.49B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.